Lymphatic filariasis

Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28

Retrieved on: 
Sunday, December 3, 2023
Philanthropy, Health, Infectious Diseases, Other Health, Fund Raising, Foundation, General Health, Lymphatic filariasis, Global health, Climate change, WHO, Investment, Map, Public holidays in Turkmenistan, ANESVAD Foundation, Onchocerciasis, Conference, Quality of life, RLM, NTD, Organization, Prevalence, USAID, Multimedia, Melinda French Gates, Helmsley, Neglected tropical diseases, Carter Center, Closed-end fund, Face, Bill, The Fred Hollows Foundation, Foreign Affairs, Laboratory, Infection, Partnership, World Health Organization, Research, Dracunculiasis, Hope, COP28, Carter, Poverty, Demographics of Tanzania, LF, RVNG Intl., Trypanosomiasis, Medical device, Renewable energy, Pharmaceutical industry, Agriculture, Sanitation

The forum took place on the first ever Health Day during the United Nations Climate Change Conference (COP28).

Key Points: 
  • The forum took place on the first ever Health Day during the United Nations Climate Change Conference (COP28).
  • His Highness Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs, UAE, was joined by world leaders including H.E.
  • Dr Austin Demby, Minister of Health and Sanitation, Sierra Leone, in a demonstration of endemic country leadership against NTDs.
  • The collaborative efforts of countries and global donors exemplify an unwavering dedication to improving the lives of the 1.6 billion people affected by these diseases.

Lao PDR Reaches Incredible Milestone in Mitigating Neglected Tropical Diseases with Elimination of Lymphatic Filariasis

Retrieved on: 
Wednesday, October 18, 2023
WHO, PDR, Elephantiasis, Neglected tropical diseases, Lao people, International development, United, Asian Development Bank, Government, FHI360, Albendazole, RESEARCH, East, Filariasis, Lymphatic filariasis, GSK plc, RTI, Disease, Democratic republic, USAID, World Health Organization, Risk, Disability, Trachoma, Public, PARK, NTD, RTI International, Tutoring, Pharmaceutical industry

RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2023 /PRNewswire/ -- RTI International, a nonprofit research institute and leading international development organization, joins the Lao People's Democratic Republic (Lao PDR), World Health Organization, and the U.S. Agency for International Development (USAID) in celebrating Lao PDR's achievement of eliminating lymphatic filariasis as a public health problem. 

Key Points: 
  • WHO officially confirmed this week that the people of Lao PDR are no longer at risk of contracting the disease.
  • "It is particularly significant given that Lao PDR achieved the elimination of trachoma as public health problem in 2017, demonstrating the power of national commitment to ending neglected tropical diseases."
  • We are proud to be among the partners that supported the Lao PDR Ministry of Health to achieve this important milestone for its people."
  • The elimination of lymphatic filariasis in Lao PDR was supported by many partners including USAID, RTI, FHI360, WHO, Mac Foundation, and the Asian Development Bank.

CBM Distributes 600 Millionth Drug Dose to Protect Against Neglected Tropical Diseases

Retrieved on: 
Thursday, January 26, 2023
Professional Services, Pharmaceutical, Philanthropy, Consumer, Medical Devices, Infectious Diseases, Fund Raising, Foundation, Medical Supplies, Religion, Environmental, Social and Governance (ESG), Health, Lymphatic filariasis, Disability, GSK, Neglected tropical diseases, Albendazole, NTD, Investment, Pain, Deformity, Poverty, LF, Friends, Family, Risk, Parent, Surayya (film), Merck, CBM, Disease, Partner, Multimedia, Paratriathlon, Tablet, Vaccine

Simple treatments can protect people from Neglected Tropical Diseases (NTDs), which, if left untreated, lead to disabilities, including blindness and disfiguration.

Key Points: 
  • Simple treatments can protect people from Neglected Tropical Diseases (NTDs), which, if left untreated, lead to disabilities, including blindness and disfiguration.
  • Christian Blind Mission (CBM) recently celebrated the milestone of the 600 millionth dose of medicines to protect communities from NTDs.
  • View the full release here: https://www.businesswire.com/news/home/20230126005499/en/
    Surayya was the recipient of the 600 millionth dose against NTDs administered by CBM with their partners.
  • CBM trains health workers and ensures that community members have access to clean water and sanitary facilities – all of which helps in the fight against neglected tropical diseases.

GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases

Retrieved on: 
Friday, November 11, 2022
Wolbachia, Health, Adult, Investment, Wellcome, Vaccine, United Nations, Global Health Innovative Technology Fund, Partnership, Research, Lymphatic filariasis, Bill & Melinda Gates Foundation, United Nations Development Programme, Malaria, US, Government of Japan, PPP, Lymph, Degenerative disease, Onchocerciasis, Neglected tropical diseases, Tuberculosis, Patient, Elephantiasis, Bill, UNDP, CEO, Pharmaceutical industry

TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 790 million yen (US$5.3 million*) to invest in product development for lymphatic filariasis and onchocerciasis, two neglected tropical diseases (NTDs).

Key Points: 
  • TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 790 million yen (US$5.3 million*) to invest in product development for lymphatic filariasis and onchocerciasis, two neglected tropical diseases (NTDs).
  • Neglected tropical diseases caused by parasitic infection: New drug development for lymphatic filariasis and onchocerciasis
    Lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness) are two neglected tropical diseases that are caused by parasitic worms.
  • The GHIT Fund invests and manages an R&D portfolio of development partnerships aimed at neglected diseases, such as malaria, tuberculosis and neglected tropical diseases that afflict the world's vulnerable and underserved populations.
  • The GHIT Fund mobilizes the Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

Cameroon and the Mectizan Donation Program sign historic agreement to end neglected tropical diseases

Retrieved on: 
Wednesday, July 20, 2022
Onchocerciasis, Filariasis, NGO, World, Tuberculosis, Population, Center, Research, Tablet, Partnership, Government, Lymphatic filariasis, Merck & Co., Malaria, World Health Organization, Quality of life, LF, Ministry, Merck, SDG, Non-governmental organization, National Center for Research Resources, MDP, Program, United Nations Sustainable Development Group, HIV, Ministry of Public Health (Afghanistan), Public health, Pharmaceutical industry

In the agreement, MDP commits to continuing to make available, free of charge, enough Mectizan for Cameroon's river blindness and LF elimination effort until the World Health Organization declares Cameroon to be free of both diseases.

Key Points: 
  • In the agreement, MDP commits to continuing to make available, free of charge, enough Mectizan for Cameroon's river blindness and LF elimination effort until the World Health Organization declares Cameroon to be free of both diseases.
  • The signing of this agreement is an important step to achieving the elimination targets set by the World Health Organization's Neglected Tropical Diseases Road Map 2021-2030.
  • It will also help to meet the United Nations Sustainable Development Goals (SDG), specifically SDG 3.3to "end the epidemics of HIV, tuberculosis, malaria and neglected tropical diseases" by 2030.
  • The Mectizan Donation Program (MDP) oversees the donation of Mectizan by Merck & Co., Inc., Rahway, New Jersey, USA to eligible countries where river blindness and/or lymphatic filariasis are endemic.

DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

Retrieved on: 
Tuesday, June 7, 2022
Science, Lists of record labels, Life, Human, Leadership, Death, Research, IPO, LLC, GMA, Patent, Chikungunya, Security (finance), Lymphatic filariasis, DSS, Malaria, Biomedicine, Sustainable energy, Solution, Global, Sale, China National Intellectual Property Administration, Zika fever, Investment management, National, GLOBE, Diabetes, Technology, Digital transformation, NYSE, Fever Dream, Alternative trading organization, Drug discovery, Food preservation, Agriculture, Medical device, Biotechnology

This complements the corresponding U.S. patent granted (U.S. 11,246,310)

Key Points: 
  • This complements the corresponding U.S. patent granted (U.S. 11,246,310)
    3F is an extremely effective mosquito repellant.
  • The repellant is believed to incapacitate two of the three receptors that mosquitoes use to find sources of nutrition.
  • Impact Biomedical and GRDG announced a U.S. patent (US 10,966,424) allowance for 3FDB in June 2021.
  • Impact BioMedical drives mission-oriented research, development, and commercialization of solutions for medical advances in human wellness and healthcare.

GLIDE: Yemeni Doctor Wins Global Disease Elimination Award to Help Keep the Country Free of Lymphatic Filariasis

Retrieved on: 
Monday, December 13, 2021
Philanthropy, Health, Infectious Diseases, Foundation, Pharmaceutical, Biotechnology, Award, EXPO, Neglected tropical diseases, Lymphatic filariasis, Health, Poverty, World, Onchocerciasis, Polio, Universal health care, World Health Organization, Achievement, The Global Institute for Tomorrow, Bill, Health status of White Americans, Leprosy, Maltese Falcon Society, The Bill, Partnership, Tameem Al-Kubati, LF, Pharmaceutical industry, Medical device, Management, Malaria, GLIDE, the Falcon Awards for Disease Elimination, GLIDE, THE FALCON AWARDS FOR DISEASE ELIMINATION

Dr Abdul Samid Al-Kubati, a doctor who is leading Yemens efforts to keep the country rid of lymphatic filariasis (LF) has won a Falcon Award for Disease Elimination.

Key Points: 
  • Dr Abdul Samid Al-Kubati, a doctor who is leading Yemens efforts to keep the country rid of lymphatic filariasis (LF) has won a Falcon Award for Disease Elimination.
  • The five winners were announced yesterday by the Global Institute for Disease Elimination (GLIDE) during a Universal Health Coverage Day event at EXPO 2020 Dubai.
  • Dr Al-Kubati beat 220 applicants across 44 countries to become the first Yemeni winner of the Falcon Awards.
  • The Awards invited submissions from organisations in disease-endemic countries whose proposals address cross-border, cross-disease, cross-programme, or cross-sector approaches to disease elimination.

GLIDE: Vaccination Incentives and Next Generation Sequencing – Two Pakistani Doctors Employ Innovative Techniques to Eradicate Polio

Retrieved on: 
Monday, December 13, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Infectious Diseases, Method, Award, NIH, Government, Vaccination, EXPO, Neglected tropical diseases, Lymphatic filariasis, Child, Poverty, Last mile, COVID-19, Epidemiology, Polio, National Institute, Universal health care, Foundation for the National Institutes of Health, Disease, Poliovirus, Bill, The Global Institute for Tomorrow, Infection, Onchocerciasis, Aga Khan University, Maltese Falcon Society, The Bill, Public health, Division, Partnership, Assistant, Technology, Certification, Pediatric nursing, Medical device, Vaccine, Pharmaceutical industry, Management, Malaria, Woman, GLIDE, the Falcon Awards for Disease Elimination, GLIDE, THE FALCON AWARDS FOR DISEASE ELIMINATION

Pending further successes, there are plans to scale-up Dr Das approach in all 40 high-risk areas in Pakistan.

Key Points: 
  • Pending further successes, there are plans to scale-up Dr Das approach in all 40 high-risk areas in Pakistan.
  • It is possible his methods could also be used to control other infectious diseases in the region, including COVID-19.
  • With GLIDEs support, my project will focus on improving polio vaccination coverage in these high-risk areas which will hopefully contribute to eradicating this disease from the world.
  • Dr Das and Dr Salman beat 220 applicants across 44 countries to become the first Pakistani winners of the Falcon Awards.

GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor

Retrieved on: 
Monday, December 13, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Infectious Diseases, Research Institute for Tropical Medicine, Award, EXPO, Neglected tropical diseases, Lymphatic filariasis, Tropical medicine, Android, Poverty, Medical specialty, Polio, Universal health care, Patient, Department, The Global Institute for Tomorrow, Prevalence, Bill, Onchocerciasis, Department of Health (Philippines), Maltese Falcon Society, The Bill, Partnership, LF, Pharmaceutical industry, Medicine, Management, Malaria, GLIDE, the Falcon Awards for Disease Elimination, GLIDE, THE FALCON AWARDS FOR DISEASE ELIMINATION

Great achievements have been made in the Philippines to tackle malaria and LF to date.

Key Points: 
  • Great achievements have been made in the Philippines to tackle malaria and LF to date.
  • However, elimination of these diseases remains problematic, and over the last five years, the country has struggled to reduce their prevalence.
  • Dr Espino beat 220 applicants across 44 countries to become the first Filipino winner of the Falcon Awards.
  • Great achievements have been made towards the 2030 goal of the elimination of malaria and lymphatic filariasis.

The Global Institute for Disease Elimination awards USD1 million to ground-breaking health projects in endemic countries

Retrieved on: 
Sunday, December 12, 2021
Infectious Diseases, Pharmaceutical, Health, Other Health, Research Institute for Tropical Medicine, Closed-end fund, Award, Government, EXPO, Neglected tropical diseases, Lymphatic filariasis, Tropical medicine, Android, Health, Poverty, World, Medical research, Epidemiology, Medical specialty, Polio, Universal Health Coverage Day, Universal health care, Patient, World Health Organization, Disease, Poliovirus, The Global Institute for Tomorrow, Department, Noguchi Memorial Institute for Medical Research, Bill, Health status of White Americans, Onchocerciasis, Aga Khan University, Florida Department of Health, The Bill, Public health, Division, Assistant, Technology, Pediatric nursing, Pharmaceutical industry, Vaccine, Management, Malaria, Woman, GLIDE, the Falcon Awards for Disease Elimination, GLIDE, THE FALCON AWARDS FOR DISEASE ELIMINATION

The Global Institute for Disease Elimination (GLIDE) has announced the winners of its inaugural Falcon Awards for Disease Elimination.

Key Points: 
  • The Global Institute for Disease Elimination (GLIDE) has announced the winners of its inaugural Falcon Awards for Disease Elimination.
  • The Falcon Awards will support community-based initiatives by empowering local actors with the tools and financial backing to rid the world of these preventable diseases.
  • For more information on The Falcon Awards for Disease Elimination and the winners, please visit: https://glideae.org/awards
    For photos of the winners, please click here .
  • The Awards invited submissions from organisations in disease-endemic countries whose proposals address cross-border, cross-disease, cross-programme, or cross-sector approaches to disease elimination.